Compare top Hodgkin's lymphoma doctors and prices in Israel. Find your best match here.
We'll hand-pick the best doctors based on your needs and budget.
Meet the experts behind this page
Medically reviewed by Fahad Mawlood
Medical Editor & Data ScientistTop doctors
19
Israel
Reviews
14,000+
From real patients
Get free personalized treatment plans and choose the best option. No commitment · No payments for our services
Show first:
Head of the Hematology Department at Sourasky Medical Center, leading the hospital's team for blood cancer care.
Performed several hundred stem cell transplants – Dr. Ram specializes in complex cases requiring this advanced procedure at Sourasky Medical Center.
Dr. Ronit El Hasid has performed 300+ pediatric bone marrow and umbilical blood transplants, leading the department at Sourasky's Dana Dwek Children's Hospital.
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.
Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.
She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.
She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.
She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.
Dr. Shapira works at Sourasky Medical Center's Bone Marrow Transplantation department – a critical treatment for Hodgkin's lymphoma.
Dr. Aviv brings 34 years of experience of dedicated experience treating blood cancers at the renowned Sourasky Medical Center (Ichilov).
Dr. Dror Levin is a leading pediatric hematology-oncology expert at Sourasky Medical Center, specializing in blood disorders and bone cancer in children.
Dr. Herishanu Yair has received multiple prestigious awards for his hematology research and clinical excellence at Tel-Aviv Sourasky Medical Center.
Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.
She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.
Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.
Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.
She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.
Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.
Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.
He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.
He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).
Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.
He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.
He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.
Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.
He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.
Ofer Spielberg is an oncohematologist specializing in blood cancers at Assuta Medical Center.
Professor Zila Zuckerman specializes in hematology and transplantology at Rambam Medical Center.
Specializing in radiotherapy and oncology, Dr. Karen Drumea offers expert care at Rambam Medical Center.
Specialist in hematology with a focus on lymphomas, including Hodgkin's lymphoma, at Rambam Medical Center.
Choosing a clinic abroad can be stressful. At Bookimed, with over 800K patients helped, we understand your concerns. We know how to find trusted doctors, the best price-quality options, and solutions for even complex cases. We’re here to guide you every step of the way.
Yan Matsiivskiy
Head of Medical Coordinator Team
4300++ patient journeys guided
3 years at Bookimed
142 patients from Israel have found their doctor through us this month
2 min Quiz
Tell us your goal, budget, timeline
Human Matching + AI
Our algorithm finds matches, coordinator verifies fit
Your Options Ready
Compare prices, packages, dates. Chat with your coordinator
Overwhelmed by choices?
Guiding your treatment
Medically trained personal coordinators
| Rank | Doctor | experience | Good Fit For | What Sets Them Apart | Clinic & Location | Consultation |
|---|---|---|---|---|---|---|
| #1 | 24 years of experience | Hodgkin's lymphoma care | Heads the Hematology Department at a major medical center, bringing senior leadership and focused expertise to lymphoma cases. | Israel | Price on request
| |
| #2 | 24 years of experience | Stem cell transplants for lymphoma | Proficiency in complex stem cell transplants – has performed several hundred. Academic leader with 30+ publications and textbook contribution. | Israel | Price on request
| |
| #3 | 38 years of experience | Pediatric bone marrow transplants | Leads one of Israel's top pediatric transplant programs. Performed 300+ procedures with extensive research background (50+ publications). Trained at City of Hope Hospital. | Israel | Price on request
| |
| #4 | 36 years of experience | Bone marrow transplant for lymphoma | Specializes exclusively in BMT – a key advanced therapy for Hodgkin's lymphoma. A senior physician trained at the prestigious Hadassah hospital. | Israel | Price on request
| |
| #5 | 34 years of experience | Oncohematology (blood cancer) cases | Specialized in oncohematology for over three decades. Provides expert consultation online based on your medical documentation for a convenient remote review. | Israel | Price on request
| |
| #6 | 41 years of experience | Pediatric Hodgkin's lymphoma | Specializes in childhood blood cancers and sarcomas. Directs one of Israel's leading pediatric hemato-oncology programs with Rizzoli Institute training in bone tumors. | Israel | Price on request
| |
| #7 | 24 years of experience | Chronic lymphocytic leukemia | Specializes in CLL with multiple research awards. Recognized for clinical excellence at Tel-Aviv Sourasky Medical Center. Member of key hematology associations. | Israel | Price on request
| |
| #8 | Hodgkin's lymphoma and blood cancers | An oncohematologist who provides targeted, personalized treatment plans for complex blood cancers like Hodgkin's lymphoma. | Israel | Price on request
| ||
| #9 | Hematology and transplant cases | Specializes in hematology and transplantology, providing advanced treatments at Rambam Medical Center – a leading hospital in Israel. | Israel | Price on request
| ||
| #10 | Radiotherapy for Hodgkin's lymphoma | Specializes in radiotherapy, with a focus on Hodgkin's lymphoma. Affiliated with Rambam Medical Center – known for advanced oncology treatments. | Israel | Price on request
|
Choosing a doctor in Israel for Hodgkin's lymphoma treatment provides access to senior leadership at JCI-accredited centers and pioneers in CAR-T cell therapy. Many specialists hold fellowships from premier US institutions like Johns Hopkins or MD Anderson, bringing research-backed protocols to complex cases.
Bookimed Expert Insight: Israeli specialists often hold dual roles as clinicians and researchers, which speeds up the adoption of new protocols. For example, Dr. Abraham Avigdor has published 130+ studies, so his patients benefit from cutting-edge prognostic tools like integrated PET/CT scans.
Patient Consensus: Patients were impressed by how quickly doctors coordinated their care and the deep expertise shown during second opinions. They often mentioned feeling a sense of relief after specialists reviewed their cases with such precision.
English-speaking Hodgkin's lymphoma specialists in Israel practice at leading centers like Sheba and Sourasky. Many, such as Dr. Abraham Avigdor and Dr. Avichai Shimoni, completed fellowships at top US institutions and regularly publish research in English-language scientific journals.
Bookimed Expert Insight: Israeli specialists often hold dual board certifications in hematology and oncology. For example, Dr. Ron Ram is certified in both, plus internal medicine. Choosing a doctor with multiple certifications is helpful for patients with complex cases requiring both chemotherapy and cellular therapies.
Patient Consensus: Patients value doctors who explain biopsy results and treatment choices in plain English. Preparation is key, so patients often share medical records early to ensure smooth consultations without language barriers.
You can consult with an Israeli Hodgkin's lymphoma expert before traveling. Specialists like Dr. Fred Aviv and Dr. Abraham Avigdor offer remote consultations to review pathology reports. This process allows patients to confirm their diagnosis and treatment plans from home before making travel arrangements.
Bookimed Expert Insight: While many senior leaders like Dr. Ram Ron drive department protocols, specialists with 30+ years of experience like Dr. Fred Aviv are often the most accessible for initial remote reviews. Choosing a doctor who specifically offers online consultations helps finalize medical logistics and treatment sequencing faster than waiting for an in-person appointment in Tel Aviv or Ramat Gan.
Patient Consensus: Patients found that remote consults often confirmed their local plans or introduced targeted therapies. Preparing digital scans and English translations ahead of time prevented delays in receiving expert medical feedback. Many felt more confident traveling after asking their specialist exactly what would happen during the first hospital visit.
Your Hodgkin's lymphoma team in Israel includes board-certified hematologists and oncohematologists from top clinics like Sheba and Sourasky. These specialists often hold international fellowships from centers like MD Anderson or Johns Hopkins, providing you with research-backed treatment plans and advanced cellular therapies.
Bookimed Expert Insight: Israeli specialists often provide streamlined care for Hodgkin's lymphoma by holding multiple certifications in hematology and oncology. This dual expertise means one senior doctor, such as Dr. Ofer Spielberg at Assuta, can oversee your entire journey from initial diagnosis to complex immunotherapy without the need for multiple independent clinics.
Patient Consensus: Patients mention that having a dedicated team where doctors and nurses work together prevents fragmented care. They often prioritize finding specialists who are fluent in English to discuss biopsy results and treatment choices clearly. Many find that getting a pathology second opinion within the same hospital helps start treatment without delay.
Israeli hematologists actively lead international research in Hodgkin's lymphoma through clinical trials and peer-reviewed studies. Specialists at centers like Sourasky Medical Center (Ichilov) and Rambam Medical Center hold academic positions and contribute to global medical textbooks. This ensures patients receive treatment protocols based on the newest scientific evidence.
Bookimed Expert Insight: Israeli research often focuses on specialized transplant techniques for lymphoma. For example, Dr. Ronit El Hasid and Dr. Ron Ram have performed hundreds of bone marrow and umbilical blood transplants. This high volume of specialized procedures allows these doctors to contribute unique data to international oncology forums, directly helping refine survival protocols for complex hematological cases.
Patient Consensus: Patients are often impressed by how doctors explain the science behind their specific care. Many felt reassured knowing their specialist was at the forefront of the latest blood cancer studies.